筛查乳腺X线摄影因可疑钙化召回的女性中立体定向空心针活检失败:多机构观察性随访研究中的频率、原因及最终结局
该研究纳入荷兰筛查区域2009年1月至2019年7月间的624,039次筛查,其中3495名女性因可疑钙化被召回。2818名有立体定向空心针活检(SCNB)指征者中,62例(2.2%)活检失败,主要因钙化位置过深或过浅或钙化太淡。SCNB失败后恶性率为8.1%(5/62),结论认为失败率低但需密切监测。
要点
- 因可疑钙化行SCNB的失败率为2.2%(62/2794),主要原因为钙化位置过深(30例)、过浅(17例)或太淡(13例)。
- SCNB失败后恶性率为8.1%(5/62),其中随访中发现2例高级别导管原位癌。
- SCNB后标本摄影和病理均未见钙化的16例女性(0.6%,31/2732)在2年随访中无一诊断为乳腺癌。
核心结论
- 因筛查乳腺X线摄影可疑钙化行SCNB的失败率低(2.2%),但失败后乳腺癌发生率可达8.1%,需密切监测并以低阈值行手术活检。
研究设计与样本
- 多机构观察性随访研究,纳入荷兰筛查区域2009年1月至2019年7月间的624,039次筛查,回顾性分析因钙化召回女性的影像报告和病理结果,随访2年。
关键影像表现/征象
- 钙化位置过深(n=30)、过浅(n=17)或钙化太淡无法活检(n=13)是SCNB失败的主要原因。
- SCNB失败后行手术活检的10例中,检出1例中级别导管原位癌和2例浸润性癌(1例中级别、1例高级别)。
- 随访中另诊断2例导管原位癌(均为高级别)。
- 16例女性在(重复)SCNB后标本摄影和病理均未见钙化(0.6%,31/2732),2年随访无一诊断为乳腺癌。
临床应用与阅片要点
- SCNB失败后处理方式多样,作者建议密切监测并以低阈值行手术活检,因SCNB失败女性中乳腺癌发生率可达8%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We determined the failure rate of stereotactic core needle biopsy (SCNB) and its causes and final outcome in women recalled for calcifications at screening mammography.
METHODS: We included a consecutive series of 624,039 screens obtained in a Dutch screening region between January 2009 and July 2019. Radiology reports and pathology results were obtained of all recalled women during 2-year follow-up.
RESULTS: A total of 3495 women (19.6% of 17,809 recalls) were recalled for suspicious calcifications. SCNB was indicated in 2818 women, of whom 12 had incomplete follow-up and another 12 women refused biopsy. DCIS or invasive cancer was diagnosed in 880 of the remaining 2794 women (31.5%). SCNB failed in 62 women (2.2%, 36/2794). These failures were mainly due to a too posterior (n = 30) or too superficial location (n = 17) of the calcifications or calcifications too faint for biopsy (n = 13). Of these 62 women, 10 underwent surgical biopsy, yielding one DCIS (intermediate grade) and two invasive cancers (one intermediate grade and one high grade) and another two women were diagnosed with DCIS (both high grade) at follow-up. Thus, the malignancy rate after SCNB failure was 8.1% (5/62). Calcifications were depicted neither at SCNB specimen radiography nor at pathology in 16 women after (repeated) SCNB (0.6%, 31/2732). None of them proved to have breast cancer at 2-year follow-up.
CONCLUSIONS: The failure rate of SCNB for suspicious calcifications is low but close surveillance is warranted, as breast cancer may be present in up to 8% of these women.
KEY POINTS: • The failure rate of stereotactic core needle biopsy (SCNB) for calcifications recalled at screening mammography was 2.2%. • Failures were mainly due to calcifications that could not be reached by SCNB or calcifications too faint for biopsy. • The management after failed SCNB was various. At least, close surveillance with a low threshold for surgical biopsy is recommended as breast cancer may be present in up to 8% of women with SCNB failure.
引用
- Duijm, Strobbe, van Breest Smallenburg, et al. Failure of stereotactic core needle biopsy in women recalled for suspicious calcifications at screening mammography: frequency, causes, and final outcome in a multi-institutional, observational follow-up study. Eur Radiol. 2022. PMID: 35486173. doi:10.1007/s00330-022-08806-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。